Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Theo Clyde Manschreck, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U01MH070017 (MANSCHRECK, THEO C) Feb 1, 2006 - Dec 31, 2011
    NIH/NIMH
    Relapse Prevention: Long Acting Atypical Antipsychotics
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Shahzade C, Chun J, DeLisi LE, Manschreck TC. Patterns in adolescent cannabis use predict the onset and symptom structure of schizophrenia-spectrum disorder. Schizophr Res. 2018 Feb 02. PMID: 29402581.
    Citations:    Fields:    
  2. Pillai A, Schooler NR, Peter D, Looney SW, Goff DC, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz A, Miller DD, Severe JB, Wilson DR, Ames D, Bustillo J, Kane JM, Buckley PF. Predicting relapse in schizophrenia: Is BDNF a plausible biological marker? Schizophr Res. 2018 03; 193:263-268. PMID: 28734907.
    Citations: 2     Fields:    Translation:Humans
  3. Buckley PF, Schooler NR, Goff DC, Kopelowicz A, Lauriello J, Manschreck TC, Mendelowitz A, Miller DD, Wilson DR, Ames D, Bustillo JR, Kane JM, Looney SW. Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention Study. Psychiatr Serv. 2016 12 01; 67(12):1370-1372. PMID: 27476806.
    Citations: 1     Fields:    Translation:Humans
  4. Chun J, Peltier SJ, Yoon D, Manschreck TC, Deldin PJ. Prolongation of ERP latency and reaction time (RT) in simultaneous EEG/fMRI data acquisition. J Neurosci Methods. 2016 08 01; 268:78-86. PMID: 27172845.
    Citations: 2     Fields:    Translation:Humans
  5. Boshes RA, Manschreck TC. Less is more Redux: Scheduled intermittent dosing to protect/prevent cognitive deterioration in schizophrenia. Med Hypotheses. 2016 May; 90:79-81. PMID: 27063092.
    Citations:    Fields:    Translation:Humans
  6. Manschreck TC, Chun J, Merrill AM, Maher BA, Boshes RA, Glatt SJ, Faraone SV, Tsuang MT, Seidman LJ. Impaired motor performance in adolescents at familial high-risk for schizophrenia. Schizophr Res. 2015 Oct; 168(1-2):44-9. PMID: 26165939.
    Citations: 4     Fields:    Translation:Humans
  7. Buckley PF, Schooler NR, Goff DC, Hsiao J, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz AJ, Miller del D, Severe JB, Wilson DR, Ames D, Bustillo J, Mintz J, Kane JM. Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study. Schizophr Bull. 2015 Mar; 41(2):449-59. PMID: 24870446.
    Citations: 12     Fields:    Translation:Humans
  8. Chun J, Karam ZN, Marzinzik F, Kamali M, O'Donnell L, Tso IF, Manschreck TC, McInnis M, Deldin PJ. Can P300 distinguish among schizophrenia, schizoaffective and bipolar I disorders? An ERP study of response inhibition. Schizophr Res. 2013 Dec; 151(1-3):175-84. PMID: 24210871.
    Citations: 9     Fields:    Translation:Humans
  9. Thermenos HW, Whitfield-Gabrieli S, Seidman LJ, Kuperberg G, Juelich RJ, Divatia S, Riley C, Jabbar GA, Shenton ME, Kubicki M, Manschreck T, Keshavan MS, DeLisi LE. Altered language network activity in young people at familial high-risk for schizophrenia. Schizophr Res. 2013 Dec; 151(1-3):229-37. PMID: 24176576.
    Citations: 5     Fields:    Translation:Humans
  10. Goff DC, McEvoy JP, Citrome L, Mech AW, Bustillo JR, Gil R, Buckley P, Manschreck TC, Achtyes ED, Macklin EA. High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study. J Clin Psychopharmacol. 2013 Aug; 33(4):485-90. PMID: 23775057.
    Citations: 2     Fields:    Translation:Humans
  11. Scala S, Pousada A, Stone WS, Thermenos HW, Manschreck TC, Tsuang MT, Faraone SV, Seidman LJ. Verbal and visual-spatial memory impairment in youth at familial risk for schizophrenia or affective psychosis: a pilot study. Schizophr Res. 2013 Mar; 144(1-3):122-8. PMID: 23312552.
    Citations: 2     Fields:    Translation:Humans
  12. Osser DN, Roudsari MJ, Manschreck T. The psychopharmacology algorithm project at the Harvard South Shore Program: an update on schizophrenia. Harv Rev Psychiatry. 2013 Jan-Feb; 21(1):18-40. PMID: 23656760.
    Citations: 1     Fields:    Translation:Humans
  13. Manschreck TC, Merrill AM, Jabbar G, Chun J, Delisi LE. Frequency of normative word associations in the speech of individuals at familial high-risk for schizophrenia. Schizophr Res. 2012 Sep; 140(1-3):99-103. PMID: 22819779.
    Citations: 2     Fields:    Translation:Humans
  14. Galvez-Buccollini JA, Proal AC, Tomaselli V, Trachtenberg M, Coconcea C, Chun J, Manschreck T, Fleming J, Delisi LE. Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis. Schizophr Res. 2012 Aug; 139(1-3):157-60. PMID: 22727454.
    Citations: 15     Fields:    Translation:Humans
  15. Boshes RA, Manschreck TC, Konigsberg W. Genetics of the schizophrenias: a model accounting for their persistence and myriad phenotypes. Harv Rev Psychiatry. 2012 May-Jun; 20(3):119-29. PMID: 22716503.
    Citations: 3     Fields:    Translation:HumansAnimals
  16. Stroup TS, Appelbaum PS, Gu H, Hays S, Swartz MS, Keefe RS, Kim SY, Manschreck TC, Boshes RA, McEvoy JP, Lieberman JA. Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study. Schizophr Res. 2011 Aug; 130(1-3):47-52. PMID: 21561740.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  17. Chan RC, Wang Y, Zhao Q, Yan C, Xu T, Gong QY, Manschreck TC. Neurological soft signs in individuals with schizotypal personality features. Aust N Z J Psychiatry. 2010 Sep; 44(9):800-4. PMID: 20815666.
    Citations: 11     Fields:    Translation:Humans
  18. Chan RC, McAlonan GM, Yang B, Lin L, Shum D, Manschreck TC. Prevalence of neurological soft signs and their neuropsychological correlates in typically developing Chinese children and Chinese children with ADHD. Dev Neuropsychol. 2010; 35(6):698-711. PMID: 21038161.
    Citations: 5     Fields:    Translation:Humans
  19. Chan RC, Wang Y, Wang L, Chen EY, Manschreck TC, Li ZJ, Yu X, Gong QY. Neurological soft signs and their relationships to neurocognitive functions: a re-visit with the structural equation modeling design. PLoS One. 2009 Dec 24; 4(12):e8469. PMID: 20041110.
    Citations: 17     Fields:    Translation:Humans
  20. Manschreck TC, Boshes RA. The CATIE schizophrenia trial: results, impact, controversy. Harv Rev Psychiatry. 2007 Sep-Oct; 15(5):245-58. PMID: 17924259.
    Citations: 21     Fields:    Translation:Humans
  21. Lenzenweger MF, Miller AB, Maher BA, Manschreck TC. Schizotypy and individual differences in the frequency of normal associations in verbal utterances. Schizophr Res. 2007 Sep; 95(1-3):96-102. PMID: 17628440.
    Citations: 2     Fields:    Translation:Humans
  22. Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, Manschreck T, Freudenreich O, Johnson SA. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology. 2008 Feb; 33(3):465-72. PMID: 17487227.
    Citations: 43     Fields:    Translation:Humans
  23. Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, Walker TM, Stroup TS, McEvoy JP, Lieberman JA. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology. 2006 Sep; 31(9):2033-46. PMID: 16641947.
    Citations: 94     Fields:    Translation:HumansCTClinical Trials
  24. Manschreck TC, Khan NL. Recent advances in the treatment of delusional disorder. Can J Psychiatry. 2006 Feb; 51(2):114-9. PMID: 16989110.
    Citations: 4     Fields:    Translation:Humans
  25. Maher BA, Manschreck TC, Linnet J, Candela S. Quantitative assessment of the frequency of normal associations in the utterances of schizophrenia patients and healthy controls. Schizophr Res. 2005 Oct 15; 78(2-3):219-24. PMID: 16005190.
    Citations: 10     Fields:    Translation:Humans
  26. Lenzenweger MF, Maher BA, Manschreck TC. Paul E. Meehl's influence on experimental psychopathology: fruits of the nexus of schizotypy and schizophrenia, neurology, and methodology. J Clin Psychol. 2005 Oct; 61(10):1295-315. PMID: 16041784.
    Citations: 1     Fields:    Translation:Humans
  27. Stroup S, Appelbaum P, Swartz M, Patel M, Davis S, Jeste D, Kim S, Keefe R, Manschreck T, McEvoy J, Lieberman J. Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial. Schizophr Res. 2005 Dec 01; 80(1):1-8. PMID: 16182516.
    Citations: 11     Fields:    Translation:Humans
  28. Manschreck TC, Maher BA, Candela SF. Earlier age of first diagnosis in schizophrenia is related to impaired motor control. Schizophr Bull. 2004; 30(2):351-60. PMID: 15279052.
    Citations: 6     Fields:    Translation:Humans
  29. Boshes RA, Manschreck TC. Review of antipsychotic medication administration: a proposal of intermittent dosing. Schizophr Bull. 2002; 28(2):203-22. PMID: 12693428.
    Citations: 3     Fields:    Translation:HumansCells
  30. Boshes RA, Manschreck TC, Desrosiers J, Candela S, Hanrahan-Boshes M. Initiation of clozapine therapy in a patient with preexisting leukopenia: a discussion of the rationale of current treatment options. Ann Clin Psychiatry. 2001 Dec; 13(4):233-7. PMID: 11958365.
    Citations: 4     Fields:    Translation:Humans
  31. Manschreck TC. Placebo studies: lessons from psychiatric research. Psychiatr Ann. 2001 Feb; 31(2):130-6. PMID: 12785378.
    Citations:    Translation:Humans
  32. Manschreck TC, Maher BA, Candela SF, Redmond D, Yurgelun-Todd D, Tsuang M. Impaired verbal memory is associated with impaired motor performance in schizophrenia: relationship to brain structure. Schizophr Res. 2000 May 25; 43(1):21-32. PMID: 10828412.
    Citations: 3     Fields:    Translation:Humans
  33. Manschreck TC, Maher BA, Winzig L, Candela SF, Beaudette S, Boshes R. Age disorientation in schizophrenia: an indicator of progressive and severe psychopathology, not institutional isolation. J Neuropsychiatry Clin Neurosci. 2000; 12(3):350-8. PMID: 10956568.
    Citations: 2     Fields:    Translation:Humans
  34. Manschreck TC, Redmond DA, Candela SF, Maher BA. Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia. J Neuropsychiatry Clin Neurosci. 1999; 11(4):481-9. PMID: 10570762.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  35. Maher BA, Manschreck TC, Yurgelun-Todd DA, Tsuang MT. Hemispheric asymmetry of frontal and temporal gray matter and age of onset in schizophrenia. Biol Psychiatry. 1998 Sep 15; 44(6):413-7. PMID: 9777170.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  36. White MS, Maher BA, Manschreck TC. Hemispheric specialization in schizophrenics with perceptual aberration. Schizophr Res. 1998 Aug 17; 32(3):161-70. PMID: 9720121.
    Citations:    Fields:    Translation:Humans
  37. Kammer T, Saleh F, Oepen G, Seyyedi S, Kanwisher N, Furmanski C, Spitzer M. Repetition blindness in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci. 1998; 248(3):136-40. PMID: 9728732.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  38. Manschreck TC, Maher BA, Beaudette SM, Redmond DA. Context memory in schizoaffective and schizophrenic disorders. Schizophr Res. 1997 Aug 29; 26(2-3):153-61. PMID: 9323346.
    Citations: 4     Fields:    Translation:Humans
  39. Blyler CR, Maher BA, Manschreck TC, Fenton WS. Line drawing as a possible measure of lateralized motor performance in schizophrenia. Schizophr Res. 1997 Jul 25; 26(1):15-23. PMID: 9376334.
    Citations: 2     Fields:    Translation:Humans
  40. Maher BA, Manschreck TC, Redmond D, Beaudette S. Length of illness and the gradient from positive to negative semantic priming in schizophrenic patients. Schizophr Res. 1996 Nov 15; 22(2):127-32. PMID: 8958596.
    Citations: 5     Fields:    Translation:Humans
  41. Manschreck TC. Delusional disorder: the recognition and management of paranoia. J Clin Psychiatry. 1996; 57 Suppl 3:32-8; discussion 49. PMID: 8626368.
    Citations: 5     Fields:    Translation:Humans
  42. Manschreck TC. Pathogenesis of delusions. Psychiatr Clin North Am. 1995 Jun; 18(2):213-29. PMID: 7659595.
    Citations:    Fields:    Translation:Humans
  43. Maher BA, Manschreck TC, Woods BT, Yurgelun-Todd DA, Tsuang MT. Frontal brain volume and context effects in short-term recall in schizophrenia. Biol Psychiatry. 1995 Feb 01; 37(3):144-50. PMID: 7727622.
    Citations: 8     Fields:    Translation:Humans
  44. Manschreck TC, Redmond DA, Beaudette SM. Clozapine in the back wards. Ann Clin Psychiatry. 1994 Dec; 6(4):215-25. PMID: 7647831.
    Citations:    Fields:    Translation:Humans
  45. Welch J, Manschreck T, Redmond D. Clozapine-induced seizures and EEG changes. J Neuropsychiatry Clin Neurosci. 1994; 6(3):250-6. PMID: 7950347.
    Citations: 11     Fields:    Translation:Humans
  46. Manschreck TC. The treatment of cocaine abuse. Psychiatr Q. 1993; 64(2):183-97. PMID: 8316599.
    Citations: 1     Fields:    Translation:Humans
  47. Manschreck TC, Leighton AH. Reducing disability in mood disorders and schizophrenia. Hosp Community Psychiatry. 1992 Feb; 43(2):179-80. PMID: 1572619.
    Citations: 1     Fields:    Translation:Humans
  48. Manschreck TC, Maher BA, Rosenthal JE, Berner J. Reduced primacy and related features in schizophrenia. Schizophr Res. 1991 Jul-Aug; 5(1):35-41. PMID: 1677264.
    Citations: 4     Fields:    Translation:Humans
  49. Manschreck TC, Maher B, Celada MT, Schneyer M, Fernandez R. Object chaining and thought disorder in schizophrenic speech. Psychol Med. 1991 May; 21(2):443-6. PMID: 1876648.
    Citations:    Fields:    Translation:Humans
  50. Manschreck TC, Schneyer ML, Weisstein CC, Laughery J, Rosenthal J, Celada T, Berner J. Freebase cocaine and memory. Compr Psychiatry. 1990 Jul-Aug; 31(4):369-75. PMID: 2387150.
    Citations: 11     Fields:    Translation:Humans
  51. Wilson SN, Surman OS, Colvin R, Ozonoff D, Gelenberg AJ, Jenike MA, Manschreck T, Pato C. Unusual lymphocyte subset distribution in some depressed patients. J Clin Psychiatry. 1990 Feb; 51(2):51-2. PMID: 2137122.
    Citations: 1     Fields:    Translation:HumansCells
  52. Manschreck TC, Keuthen NJ, Schneyer ML, Celada MT, Laughery J, Collins P. Abnormal involuntary movements and chronic schizophrenic disorders. Biol Psychiatry. 1990 Jan 15; 27(2):150-8. PMID: 2294979.
    Citations: 5     Fields:    Translation:Humans
  53. Garber HJ, Weilburg JB, Duffy FH, Manschreck TC. Clinical use of topographic brain electrical activity mapping in psychiatry. J Clin Psychiatry. 1989 Jun; 50(6):205-11. PMID: 2637676.
    Citations: 2     Fields:    Translation:Humans
  54. Maher BA, Manschreck TC, Weisstein CC, Schneyer ML, Okunieff R. Cloze analysis in schizophrenic speech: scoring method and raters' education. Percept Mot Skills. 1988 Dec; 67(3):911-8. PMID: 3226847.
    Citations:    Fields:    Translation:Humans
  55. Zusky PM, Biederman J, Rosenbaum JF, Manschreck TC, Gross CC, Weilberg JB, Gastfriend DR. Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study. J Clin Psychopharmacol. 1988 Apr; 8(2):120-4. PMID: 3131389.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  56. Manschreck TC, Laughery JA, Weisstein CC, Allen D, Humblestone B, Neville M, Podlewski H, Mitra N. Characteristics of freebase cocaine psychosis. Yale J Biol Med. 1988 Mar-Apr; 61(2):115-22. PMID: 3407210.
    Citations: 6     Fields:    Translation:Humans
  57. Manoach DS, Maher BA, Manschreck TC. Left-handedness and though disorder in the schizophrenias. J Abnorm Psychol. 1988 Feb; 97(1):97-9. PMID: 3351121.
    Citations:    Fields:    Translation:Humans
  58. Garber HJ, Weilburg JB, Buonanno FS, Manschreck TC, New PF. Use of magnetic resonance imaging in psychiatry. Am J Psychiatry. 1988 Feb; 145(2):164-71. PMID: 3341461.
    Citations: 1     Fields:    Translation:Humans
  59. Manschreck TC, Maher BA, Milavetz JJ, Ames D, Weisstein CC, Schneyer ML. Semantic priming in thought disordered schizophrenic patients. Schizophr Res. 1988 Jan-Feb; 1(1):61-6. PMID: 3154508.
    Citations: 33     Fields:    Translation:Humans
  60. Beckett A, Manschreck T. Neuropsychiatric complications of HIV infection: public policy implications. N Engl J Public Policy. 1988 Winter-Spring; 4(1):111-9. PMID: 11650192.
    Citations:    Translation:HumansPHPublic Health
  61. Manschreck TC, Allen DF, Neville M. Freebase psychosis: cases from a Bahamian epidemic of cocaine abuse. Compr Psychiatry. 1987 Nov-Dec; 28(6):555-64. PMID: 3691079.
    Citations: 2     Fields:    Translation:Humans
  62. Beckett A, Summergrad P, Manschreck T, Vitagliano H, Henderson M, Buttolph ML, Jenike M. Symptomatic HIV infection of the CNS in a patient without clinical evidence of immune deficiency. Am J Psychiatry. 1987 Oct; 144(10):1342-4. PMID: 3661770.
    Citations: 2     Fields:    Translation:HumansCells
  63. Manschreck TC, Ames D, Maher BA, Schneyer ML. Impoverished written responses and negative features of schizophrenia. Percept Mot Skills. 1987 Jun; 64(3 Pt 2):1163-9. PMID: 3627917.
    Citations:    Fields:    Translation:Humans
  64. Zusky P, Manschreck TC, Blanchard C, Rosenbaum J, Elliot C, Lou P. Dothiepin hydrochloride: treatment efficacy and safety. J Clin Psychiatry. 1986 Oct; 47(10):504-7. PMID: 3531188.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  65. Pollack MH, Manschreck TC. Oculocutaneous albinism and schizophrenia. Biol Psychiatry. 1986 Jul; 21(8-9):830-3. PMID: 3730462.
    Citations: 1     Fields:    Translation:Humans
  66. Uzogara E, Sheehan DV, Manschreck TC, Jones KJ. A combination drug treatment for acute common migraine. Headache. 1986 May; 26(5):231-6. PMID: 3522481.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  67. Manschreck TC, Maher BA, Waller NG, Ames D, Latham CA. Deficient motor synchrony in schizophrenic disorders: clinical correlates. Biol Psychiatry. 1985 Sep; 20(9):990-1002. PMID: 4027317.
    Citations: 3     Fields:    Translation:Humans
  68. Manschreck TC, Maher BA, Hoover TM, Ames D. Repetition in schizophrenic speech. Lang Speech. 1985 Jul-Sep; 28 ( Pt 3):255-68. PMID: 3836315.
    Citations: 2     Fields:    Translation:Humans
  69. Sederer LI, Katz B, Manschreck TC. Inpatient psychiatry: perspectives from the general, the private, and the state hospital. Gen Hosp Psychiatry. 1984 Jul; 6(3):180-90. PMID: 6745644.
    Citations: 1     Fields:    Translation:Humans
  70. Manschreck TC, Ames D. Neurologic features and psychopathology in schizophrenic disorders. Biol Psychiatry. 1984 May; 19(5):703-19. PMID: 6145453.
    Citations: 11     Fields:    Translation:Humans
  71. Manschreck TC, Maher BA, Hoover TM, Ames D. The type--token ratio in schizophrenic disorders: clinical and research value. Psychol Med. 1984 Feb; 14(1):151-7. PMID: 6709781.
    Citations:    Fields:    Translation:Humans
  72. Maher BA, Manschreck TC, Molino MA. Redundancy, pause distributions and thought disorder in schizophrenia. Lang Speech. 1983 Apr-Jun; 26 ( Pt 2):191-9. PMID: 6664181.
    Citations: 2     Fields:    Translation:Humans
  73. Sheehan DV, Davidson J, Manschreck T, Van Wyck Fleet J. Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. J Clin Psychopharmacol. 1983 Feb; 3(1):28-31. PMID: 6403599.
    Citations: 7     Fields:    Translation:Humans
  74. Manschreck TC. Psychopathology of motor behavior in schizophrenia. Prog Exp Pers Res. 1983; 12:53-99. PMID: 6364228.
    Citations: 3     Fields:    Translation:Humans
  75. Manschreck TC, Maher BA, Rucklos ME, Vereen DR. Disturbed voluntary motor activity in schizophrenic disorder. Psychol Med. 1982 Feb; 12(1):73-84. PMID: 6123128.
    Citations: 12     Fields:    Translation:Humans
  76. Manschreck TC. Current concepts in psychiatry: schizophrenic disorders. N Engl J Med. 1981 Dec 31; 305(27):1628-32. PMID: 7031470.
    Citations: 1     Fields:    Translation:Humans
  77. Keller MB, Manschreck TC. The bedside mental status examination--reliability and validity. Compr Psychiatry. 1981 Sep-Oct; 22(5):500-11. PMID: 7187871.
    Citations:    Fields:    Translation:Humans
  78. Latham C, Holzman PS, Manschreck TC, Tole J. Optokinetic nystagmus and pursuit eye movements in schizophrenia. Arch Gen Psychiatry. 1981 Sep; 38(9):997-1003. PMID: 7283672.
    Citations: 5     Fields:    Translation:Humans
  79. Manschreck TC, Maher BA, Rucklos ME, Vereen DR, Ader DN. Deficient motor synchrony in schizophrenia. J Abnorm Psychol. 1981 Aug; 90(4):321-8. PMID: 7264062.
    Citations: 4     Fields:    Translation:Humans
  80. Manschreck TC, Maher BA, Ader DN. Formal thought disorder, the type-token ratio and disturbed voluntary motor movement in schizophrenia. Br J Psychiatry. 1981 Jul; 139:7-15. PMID: 6117348.
    Citations: 4     Fields:    Translation:Humans
  81. Manschreck TC, Kalotkin M, Jacobson AM. Utility of electromyographic biological feedback in chronic stuttering: a clinical study with follow-up. Percept Mot Skills. 1980 Oct; 51(2):535-40. PMID: 7443374.
    Citations:    Fields:    Translation:Humans
  82. Maher BA, Manschreck TC, Rucklos ME. Contextual constraint and the recall of verbal material in schizophrenia: the effect of thought disorder. Br J Psychiatry. 1980 Jul; 137:69-73. PMID: 7459542.
    Citations: 3     Fields:    Translation:Humans
  83. Manschreck TC, Maher BA, Rucklos ME. Cloze procedure and written language in schizophrenia. Lang Speech. 1980; 23(Pt 4):323-8. PMID: 7266188.
    Citations:    Fields:    Translation:Humans
  84. Neu C, Manschreck TC, Flocks JM. Renal damage associated with long term use of lithium carbonate. J Clin Psychiatry. 1979 Nov; 40(11):460-3. PMID: 489527.
    Citations:    Fields:    Translation:Humans
  85. Kalotkin M, Manschreck T, O'Brien D. Electromyographic tension levels in stutterers and normal speakers. Percept Mot Skills. 1979 Aug; 49(1):109-10. PMID: 503723.
    Citations: 1     Fields:    Translation:Humans
  86. Manschreck TC. The assessment of paranoid features. Compr Psychiatry. 1979 Jul-Aug; 20(4):370-7. PMID: 455954.
    Citations: 1     Fields:    Translation:Humans
  87. Manschreck TC, Kleinman AM. Psychiatry's identity crisis: a critical rational remedy. Gen Hosp Psychiatry. 1979 Jul; 1(2):166-73. PMID: 499787.
    Citations:    Fields:    Translation:Humans
  88. Jacobson AM, Manschreck TC, Silverberg E. Behavioral treatment for Raynaud's disease: a comparative study with long-term follow-up. Am J Psychiatry. 1979 Jun; 136(6):844-6. PMID: 375758.
    Citations: 9     Fields:    Translation:Humans
  89. Manschreck TC, Maher BA, Rucklos ME, White MT. The predictability of thought disordered speech in schizophrenic patients. Br J Psychiatry. 1979 Jun; 134:595-601. PMID: 476370.
    Citations: 2     Fields:    Translation:Humans
  90. Manschreck TC, Petri M. The atypical psychoses. Cult Med Psychiatry. 1978 Sep; 2(3):233-68. PMID: 710173.
    Citations: 4     Fields:    Translation:Humans
  91. Manschreck TC, Petri M. The paranoid syndrome. Lancet. 1978 Jul 29; 2(8083):251-3. PMID: 79043.
    Citations: 1     Fields:    Translation:Humans
  92. Jacobson AM, Silverberg E, Hackett T, Manschreck T. Treatment of Raynaud's disease: evaluation of a behavioral approach. Psychiatr Clin (Basel). 1978; 11(3):125-31. PMID: 368891.
    Citations:    Fields:    Translation:Humans
  93. Jacobson G, Baldessarini RJ, Manschreck T. Tardive and withdrawal dyskinesia associated with haloperidol. Am J Psychiatry. 1974 Aug; 131(8):910-3. PMID: 4834709.
    Citations: 7     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Manschreck's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (336)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.